1. Home
  2. CYTK vs HRL Comparison

CYTK vs HRL Comparison

Compare CYTK & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

SELL

Current Price

$62.30

Market Cap

10.7B

Sector

Health Care

ML Signal

SELL

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

SELL

Current Price

$20.37

Market Cap

10.6B

ML Signal

SELL

Company Overview

Basic Information
Metric
CYTK
HRL
Founded
1997
1891
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Meat/Poultry/Fish
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
10.6B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
CYTK
HRL
Price
$62.30
$20.37
Analyst Decision
Strong Buy
Hold
Analyst Count
23
10
Target Price
★ $109.40
$25.31
AVG Volume (30 Days)
2.0M
★ 4.2M
Earning Date
11-04-2026
12-03-2026
Dividend Yield
N/A
★ 5.79%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.72
Revenue
$13,368,000.00
★ $12,106,160,000.00
Revenue This Year
$72.63
$0.18
Revenue Next Year
$181.06
$1.84
P/E Ratio
★ N/A
$28.01
Revenue Growth
N/A
★ 1.55
52 Week Low
$54.30
$18.96
52 Week High
$88.31
$26.60

Technical Indicators

Market Signals
Indicator
CYTK
HRL
Relative Strength Index (RSI) 36.80 50.08
Support Level $59.21 $19.56
Resistance Level $67.65 $20.38
Average True Range (ATR) 2.01 0.37
MACD 0.31 0.17
Stochastic Oscillator 34.67 82.74

Price Performance

Historical Comparison
CYTK
HRL

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (less than 6%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

Share on Social Networks: